课题基金 / 基金详情

MIRDCalc – A Community Tool for Deriving and Reporting Patient Organ Doses in Nuclear Medicine, Computed Tomography, and Hybrid Imaging

MIRDCalc – A Community Tool for Deriving and Reporting Patient Organ Doses in Nuclear Medicine, Computed Tomography, and Hybrid Imaging
MIRDCalc — 用于导出和报告核医学、计算机断层扫描和混合成像中患者器官剂量的社区工具
批准号:
10696129
负责人:
WESLEY E BOLCH
金额:
$60.78万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-09-13 至 2025-05-31
关键词:
AddressAdoptionAnimalsArchitectureArchivesBenefits and RisksBig DataBiodistributionBiomedical ResearchChildhoodClinicalCodeCommunitiesComplexComputed Tomography ScannersComputer softwareCosts and BenefitsDataDatabasesDerivation procedureDetectionDevelopmentDiagnosticDiagnostic ImagingDiagnostic radiologic examinationDigital Imaging and Communications in MedicineDiscipline of Nuclear MedicineDiseaseDocumentationDoseEvidence Based MedicineFDA approvedFeedbackFloridaFutureGenerationsGrowthHealthHealthcareHybridsImageImaging TechniquesInfrastructureInstitutionIsotopesLibrariesLow Dose RadiationMalignant NeoplasmsMedicalMedical ImagingModalityModelingModernizationMonte Carlo MethodNuclearOrganOutcomePatient CarePatientsPenetrationPhysicsPlayPopulationPositron-Emission TomographyProceduresProtocols documentationRadiationRadiation Dose UnitRadiation therapyRadioisotopesRadiology SpecialtyRadiopharmaceuticalsReportingReproducibilityResearchResourcesRisk AssessmentRoentgen RaysRoleSeriesSiteSoftware DesignSoftware ToolsSoftware ValidationSourceStandardizationTechniquesTechnologyTestingTherapeuticTherapy trialTimeUncertaintyUniversitiesUpdateX-Ray Computed Tomographyabsorptioncancer therapyclinical decision-makingcostdesigndosimetryepidemiology studyimage archival systemimprovedinnovationmolecular imagingmolecular targeted therapiesmultidisciplinarynuclear imagingpersonalized medicineresponserisk minimizationsimulationsingle photon emission computed tomographytooltreatment optimizationtumorweb platform

项目摘要

项目成果

WESLEY E BOLCH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary The assessment of radiation organ absorbed dose to patients plays a critical role in both the development and clinical use of radiopharmaceuticals for both diagnostic imaging (cancer/disease detection) and radiation therapy (cancer treatment). Dosimetry also provides the basis of imaging/treatment optimization, and its accessibility and maturation will help define personalized medicine as applied to medical imaging and nuclear therapies in the coming decades. A variety of software codes exist for patient dosimetry in nuclear medicine, but they tend to reside within two extremes of functionality. At one end are more simplistic NM dosimetry tools that merge animal- derived or personalized biodistribution data with standard (population-averaged) models, a technique that has proved valuable historically but has seen minimal technological advancement. At the other end are complex NM dosimetry codes that import patient-specific CT/PET/SPECT images and allow for accurate, but computationally intensive, Monte Carlo simulation-based dosimetry. The issue with these higher-end codes is that they are much more nuanced, resource intensive, and tend to only reside within research-based medical institutions with expert support staff. In this Biomedical Research Partnership between MSK and UF, a new generation of nuclear medicine patient dosimetry code will be developed and released at no cost to the imaging and clinical community. The code – MIRDcalc – is built upon the universally available Microsoft Excel platform and can be used with an easy interactive interface or automated DOS command line. The database powering MIRDcalc stores all necessary information for implementing biodistribution-to-dosimetry calculations using the MIRD schema. The current generation of MIRDcalc thus will not include acquisition and derivation of the input time-activity data, which is beyond the scope of the current application, but will be incorporated into future versions of this code. It includes radionuclide S values for 333 radioisotopes, associated with 12 modern ICRP reference phantoms each with 58 source organs and 44 target organs and is readily expandable to accommodate additional isotopes and phantoms. The MIRDcalc software will be a free tool providing dosimetry that meets current standards, and a platform for further innovations as well as a central framework for supporting a dosimetry user community. Our planned innovations address issues of personalization, uncertainty calculation, documentation, and other key considerations. Of note, and a key feature of this partnership, is the addition of CT organ dosimetry to MIRDcalc, which presently does not exist in any current nuclear medicine software code despite the universal adoption of combination PET-CT and the ever-increasing penetration of SPECT-CT scanners in diagnostic radiology and nuclear medicine.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Commercially Competitive Vendor-Agnostic Image Reconstruction Could Be a Leap Forward for PET Harmonization.
具有商业竞争力的与供应商无关的图像重建可能是 PET 协调的一次飞跃。
DOI: 10.2967/jnumed.121.263421
发表时间: 2022
期刊: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
影响因子: --
作者: [Kesner,AdamL]
通讯作者: Kesner,AdamL
Microscale Radionuclide S-values for αRPT
  • 批准号:
    10713711
  • 项目类别:
  • 资助金额:
    $47.7万
  • 财政年份:
    2023
  • 负责人:
    WESLEY E BOLCH
  • 依托单位:
Project 1: Deployable Software for the Rapid Assessment of Organ Dose Following Radionuclide Intakes
Project 1: Deployable Software for the Rapid Assessment of Organ Dose Following Radionuclide Intakes
Developing whole-body computational phantoms for blood dosimetry to model the impact of radiation on the immune system
  • 批准号:
    10429988
  • 项目类别:
  • 资助金额:
    $47.78万
  • 财政年份:
    2020
  • 负责人:
    WESLEY E BOLCH
  • 依托单位:
海外基金